87290975 - IO?

Information

• Trademark
• 87290975

• Source

• Serial Number

  87290975

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 05, 2017
  8 years ago

• Transaction Date

  February 12, 2024
  a year ago

• Status Date

  May 22, 2023
  2 years ago

• Published for Opposition Date

  February 25, 2020
  5 years ago

• Location Date

  March 31, 2021
  4 years ago

• Status Code

  606

• Current Location

  TMEG LAW OFFICE 105

  Employee Name

  GLASSER, CARYN

• Attorney Docket Number

  129250.00307

  Attorney Name

  Lori S. Meddings

  Law Office Assigned Location Code

  L50

• Owners

  • BTG International Limited

Case File Statements

• GS0411: (Based on 1(b)) Provision of education, namely, training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Provision of education and training, namely, developing, arranging and conducting live and online educational conferences, seminars, classes, lectures, panel discussions, workshops and programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care and distribution of course materials in connection therewith; Provision of education and training, namely, providing non-downloadable webinars in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care and distribution of course materials in connection therewith; Provision of education and training, namely, conducting online and telephonic instruction and courses in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Provision of education and training, namely, development of multi-media educational content for use with mobile devices and computers in relation to healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Arranging, and conducting educational conferences and programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Provision and publication of educational material and content, namely, publication of teaching guides, instructional materials, brochures and providing on-line non-downloadable publications in the nature of teaching guides, instructional materials, and brochures in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Conducting educational seminars in the fields healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care and distribution of course materials therewith; Information and advice relating to education and training provided online from a computer database or the internet, all relating to healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Provision of educational information, namely, providing on-line instruction in the fields healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care provided on-line from a computer database
• DM0000: The mark consists of the letters "IO" with the "2" as a superscript.
• GS0051: (Based on 44(e)) Pharmaceutical, medicinal and veterinary preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease, pharmaceutical preparations for the treatment of envenomation by snakes, veterinary preparations for the treatment of envenomation by snakes, liquid medical sealants, and liquid adhesives for use in surgical and clinical procedure; sanitary preparations for medical purposes; vaccines; pharmaceutical and medicinal preparations and substances, namely, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances, and sepsis; medical diagnostic reagents and substances, all for in vivo use; antibodies and therapeutic antibodies for use as anti-lymphocytic agents for medical use; pharmaceutical preparations in the form of foams or for use in producing foams, for sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical or veterinary purposes; chemical reagents for medical therapeutic and diagnostic purposes; chemical reagents for medical and veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes for use in the prevention and treatment of cancer, circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, and intracranial hemorrhages, cerebral hemorrages, and hematoma; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of immune disorders, namely, type 1 diabetes, psoriasis, coeliac disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of sepsis; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical or veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; chemical reagents for medical or veterinary therapeutic and medical diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; transarterial chemoembolization pharmaceutical preparations, vaccines and antitoxic sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; Pharmaceutical preparations being beads, including microscopic radioactive beads, for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive material for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive pharmaceutical preparations and consisting of radioactive material for treatment of cancerous tumors; radioactive glass beads impregnated with pharmaceutical preparations for the treatment of cancer; irradiated and radioactive microspheres used for in vivo therapeutic medical purposes, namely, beads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumors; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and/or medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in producing foams for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents
• CC0000: Color is not claimed as a feature of the mark.
• GS0441: (Based on 1(b)) Provision of medical and surgical information; Provision of medical and surgical information on-line from a computer database or from the Internet or by telecommunication means; Providing medical information; Providing a website featuring information regarding medicine, medical treatment, medical patient care, therapeutic properties of prescription drugs, pharmaceutical advice, dispensing of pharmaceuticals, medical treatment and medical patient care aftercare; Providing a website featuring medical information regarding medicine, medical treatment, medical patient care, therapeutic properties of prescription drugs, pharmaceutical advice, dispensing of pharmaceuticals, medical treatment and medical patient care aftercare; Providing healthcare information; Providing information about medical devices for use in medical procedures and surgery; Providing information about healthcare; Providing information in the field of healthcare, therapeutic properties of pharmaceuticals, medical devices for use in medical procedures and surgery, surgery, and medicine and medical patient care; Providing information in the field of healthcare, therapeutic properties of pharmaceuticals, medical devices for use in medical procedures and surgery, surgery, and medicine and medical patient care by means of computer, electronic and online databases
• GS0101: (Based on 44(e)) Surgical, medical, dental and veterinary apparatus and instruments, namely, cryoablation needles, medical syringes, electrically powered tissue ablation devices, artificial limbs, orthopaedic articles, namely, implants made of artificial materials, haemofiltration devices for medical use, apparatus for generating and transmitting ultrasound for medical and diagnostic use, surgical and medical apparatus and instruments for use in minimally invasive cryoablation procedures, electronic apparatus and instruments for use in relation to ultrasound imaging and scanning for medical and diagnostic use, and medical and diagnostic imaging units; Surgical and medical apparatus, instruments and devices for the treatment of chronic lung disease including emphysema; medical syringes, medical cannula needles, medical tubing; surgical and medical apparatus for producing and administering pharmaceutical foams; surgical and medical apparatus and instruments for producing and administering sclerosing foams; surgical and medical apparatus and instruments for producing foams for use in sclerotherapy, phlebology, angiology or proctology, sterilisation treatment or for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; surgical and medical devices for assessing the physical characteristics of such foams, namely, devices for intravenous administration of foam, medical diagnostic apparatus for analyzing the efficacy of sclerotherapy foams for medical purposes, medical diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose, and devices for monitoring the position and effect of foam in the human body; medical diagnostic devices for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins, hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for use in the circulatory system; apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery embolisation systems; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation, namely, medical devices in the nature of particles, namely, embolic microspheres for embolization; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beads, namely, microscopic glass beads, impregnated with radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours; radioactive beads, namely, radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; medical devices which use ultrasound to enhance drug delivery and/or medically activate drugs; catheters for delivery of drugs or fluids sold together as a unit with controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus sold together as a unit with controllers and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hycroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins, hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; compression bandages; surgical instruments and apparatus and medical diagnostic apparatus for use in interventional pulmonology; medical devices for use in pulmonary and thoracic surgery and procedures; medical devices for use in pulmonary and thoracic surgery, namely, lung volume reduction devices; artificial surgical implants for use in interventional pulmonology; surgical implants comprising artificial surgical implants for restoring, maintaining and improving patient breathing, and artificial surgical implants for restoring, maintaining and improving lung function; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous and benign tissues; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment incorporating computer software; surgical instruments and apparatus and medical diagnostic apparatus for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and benign prostatic hyperplasia (BPH ); medical devices used to deliver heat to target sites using electrical current through needles; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating for treatment of cancer and tumors; medical devices for ablating human and animal tissue using microwave energy; medical devices for treating cancerous and benign tissue using microwave energy; replacement and structural parts and fittings for all of the aforesaid goods
• GS0421: (Based on 1(b)) Providing on-line, non-downloadable educational software featuring instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; Information about medical research; Providing educational information in the field of medical research; Providing educational information in the field of medical research by means of computer, electronic and online databases; Information about pharmaceutical research; Providing educational information in the field of pharmaceutical research; Providing educational information in the field of pharmaceutical research by means of computer, electronic and online databases

Case File Event Statements

• 5/22/2023 - 2 years ago

  95 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/22/2023 - 2 years ago

  94 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 3/16/2023 - 2 years ago

  93 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 3/16/2023 - 2 years ago

  92 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 3/16/2023 - 2 years ago

  91 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 3/16/2023 - 2 years ago

  90 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 3/16/2023 - 2 years ago

  89 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 8/19/2022 - 2 years ago

  88 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/18/2022 - 2 years ago

  87 - SOU EXTENSION 5 GRANTED Type: EX5G

• 8/17/2022 - 2 years ago

  86 - SOU EXTENSION 5 FILED Type: EXT5

• 8/17/2022 - 2 years ago

  85 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 3/4/2022 - 3 years ago

  84 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/3/2022 - 3 years ago

  83 - SOU EXTENSION 4 GRANTED Type: EX4G

• 2/24/2022 - 3 years ago

  82 - SOU EXTENSION 4 FILED Type: EXT4

• 2/24/2022 - 3 years ago

  81 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 10/7/2021 - 3 years ago

  80 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/6/2021 - 3 years ago

  79 - SOU EXTENSION 3 GRANTED Type: EX3G

• 10/5/2021 - 3 years ago

  78 - SOU EXTENSION 3 FILED Type: EXT3

• 10/5/2021 - 3 years ago

  77 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 4/29/2021 - 4 years ago

  76 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 4/28/2021 - 4 years ago

  75 - SOU EXTENSION 2 GRANTED Type: EX2G

• 3/29/2021 - 4 years ago

  74 - SOU EXTENSION 2 FILED Type: EXT2

• 4/1/2021 - 4 years ago

  73 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/29/2021 - 4 years ago

  70 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 3/23/2021 - 4 years ago

  69 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/22/2021 - 4 years ago

  68 - SOU EXTENSION 1 GRANTED Type: EX1G

• 10/21/2020 - 4 years ago

  67 - SOU EXTENSION 1 FILED Type: EXT1

• 3/22/2021 - 4 years ago

  66 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 1/11/2021 - 4 years ago

  65 - NOTICE OF REVIVAL - E-MAILED Type: NREV

• 1/11/2021 - 4 years ago

  64 - SOU EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX

• 1/11/2021 - 4 years ago

  63 - PETITION TO REVIVE-GRANTED Type: PETG

• 1/11/2021 - 4 years ago

  62 - TEAS PETITION TO REVIVE RECEIVED Type: PROA

• 11/23/2020 - 4 years ago

  61 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 11/23/2020 - 4 years ago

  60 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 8/30/2020 - 4 years ago

  59 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 8/30/2020 - 4 years ago

  58 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 8/30/2020 - 4 years ago

  57 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 8/30/2020 - 4 years ago

  56 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/30/2020 - 4 years ago

  55 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 8/30/2020 - 4 years ago

  54 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 4/21/2020 - 5 years ago

  53 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 2/25/2020 - 5 years ago

  52 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/25/2020 - 5 years ago

  51 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/5/2020 - 5 years ago

  50 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/23/2020 - 5 years ago

  49 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 1/16/2020 - 5 years ago

  48 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/15/2020 - 5 years ago

  47 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/15/2020 - 5 years ago

  46 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/15/2020 - 5 years ago

  45 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/15/2020 - 5 years ago

  44 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/31/2019 - 5 years ago

  43 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/31/2019 - 5 years ago

  42 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/31/2019 - 5 years ago

  41 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/10/2019 - 5 years ago

  40 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 11/12/2019 - 5 years ago

  39 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 10/29/2019 - 5 years ago

  38 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/3/2019 - 5 years ago

  37 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/3/2019 - 5 years ago

  36 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/27/2019 - 5 years ago

  35 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/27/2019 - 5 years ago

  34 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/27/2019 - 5 years ago

  33 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/27/2019 - 5 years ago

  32 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 8/26/2019 - 5 years ago

  31 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/26/2019 - 5 years ago

  30 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/23/2019 - 5 years ago

  29 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 8/23/2019 - 5 years ago

  28 - EX PARTE APPEAL-INSTITUTED Type: EXPI

• 8/23/2019 - 5 years ago

  27 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT

• 8/23/2019 - 5 years ago

  26 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF

• 2/25/2019 - 6 years ago

  25 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 2/25/2019 - 6 years ago

  24 - FINAL REFUSAL E-MAILED Type: GNFR

• 2/25/2019 - 6 years ago

  23 - FINAL REFUSAL WRITTEN Type: CNFR

• 2/4/2019 - 6 years ago

  22 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/4/2019 - 6 years ago

  21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/1/2019 - 6 years ago

  20 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 10/2/2018 - 6 years ago

  19 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 9/18/2018 - 6 years ago

  18 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 3/8/2018 - 7 years ago

  17 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 3/7/2018 - 7 years ago

  16 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 9/2/2017 - 7 years ago

  15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 9/2/2017 - 7 years ago

  14 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 9/2/2017 - 7 years ago

  13 - SUSPENSION LETTER WRITTEN Type: CNSL

• 8/23/2017 - 7 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/22/2017 - 7 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/22/2017 - 7 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/7/2017 - 8 years ago

  9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/7/2017 - 8 years ago

  8 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/7/2017 - 8 years ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/4/2017 - 8 years ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 2/10/2017 - 8 years ago

  5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 2/9/2017 - 8 years ago

  4 - ASSIGNED TO LIE Type: ALIE

• 1/27/2017 - 8 years ago

  3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 1/13/2017 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/9/2017 - 8 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP